Juan Carlos Torre Alonso-rekin lankidetzan egindako argitalpenak (3)

2019

  1. Non-inferiority of dose reduction versus standard dosing of TNF-inhibitors in axial spondyloarthritis 11 Medical and Health Sciences 1117 Public Health and Health Services 11 Medical and Health Sciences 1103 Clinical Sciences

    Arthritis Research and Therapy, Vol. 21, Núm. 1

2009

  1. Relationship between spinal mobility and disease activity, function, quality of life and radiology. A cross-sectional Spanish registry of spondyloarthropathies (REGISPONSER)

    Clinical and Experimental Rheumatology, Vol. 27, Núm. 3, pp. 439-445

2003

  1. Infliximab in refractory spondyloarthropathies: A multicentre 38 week open study

    Annals of the Rheumatic Diseases, Vol. 62, Núm. 12, pp. 1239-1240